OpenVSafe by OpenVAERS
Search V-safe

CT4-47021-31316

3 vaccinations 6 coded responses 36 check-ins 6 free-text entries 4 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
207 / MD
Registered
2022-06-24
Relationship
Child or adolescent in my care
Guardian
UJ8-21181-15863
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-24
    Registered in v-safe
  2. 2022-06-24
    Dose 1 — Pfizer-BioNTech
  3. 2022-06-24
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-06-25
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-06-27
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-06-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-06-30
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-01
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-07-08
    Survey response — day 14, dose 1, under 3
    MedDRA: Productive cough, Rhinorrhoea — Feeling: Good
    Free text: Wet cough with runny nose, for about a week, but it was relatively mild.
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-07-15
    Dose 2 — Pfizer-BioNTech
  13. 2022-07-15
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-07-16
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  15. 2022-07-17
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  16. 2022-07-18
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-07-19
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-07-20
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-07-21
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-07-22
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  21. 2022-07-29
    Survey response — day 14, dose 2, under 3
    MedDRA: Erythema, Pyrexia, SARS-CoV-2 test negative, Viral infection — Feeling: Good
    Free text: He had a random virus that caused a low grade fever for about 12 hours and tiny red dots on his chest and back for about 48 hours. He tested negative on a covid home test and symptoms resolved quickly.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-08-05
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-08-12
    Survey response — day 28, dose 2, under 3
    MedDRA: Cough, Respiratory distress, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Runny nose, moderate respiratory distress, cough.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-08-12
    Report sent to call center — day 28, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  25. 2022-08-15
  26. 2022-08-15
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  27. 2022-08-19
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  28. 2022-08-26
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  29. 2022-09-16
    Dose 3 — Pfizer-BioNTech
  30. 2022-09-17
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  31. 2022-09-18
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · Diarrhea
    Under 3 check-in
  32. 2022-09-19
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  33. 2022-09-20
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  34. 2022-09-21
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  35. 2022-09-22
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  36. 2022-09-23
    Health check-in — day 7, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  37. 2022-09-30
    Survey response — day 14, dose 3, under 3
    MedDRA: Ear infection, Tympanic membrane perforation — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Ear infection that resulted in a burst eardrum.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-09-30
    Report sent to call center — day 14, dose 3, under 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  39. 2022-10-03
  40. 2022-10-03
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  41. 2022-10-07
    Health check-in — day 21, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  42. 2022-10-14
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  43. 2022-10-21
    Survey response — day 35, dose 3, under 3
    MedDRA: Cough, Ear infection, Eye pruritus, Lacrimation increased, Upper-airway cough syndrome — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Itchy, watery eyes, ear infection, post nasal drip, cough
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-10-21
    Report sent to call center — day 35, dose 3, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  45. 2022-10-24
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  46. 2022-10-28
    Health check-in — day 42, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  47. 2022-12-16
    Survey response — 3 months, dose 3, under 3
    MedDRA: Hand-foot-and-mouth disease, Nasopharyngitis, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Colds, RSV, and Hand Foot Mouth disease.
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-12-16
    Report sent to call center — 3 months, dose 3, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  49. 2022-12-19
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  50. 2023-03-17
    Health check-in — 6 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-06-24Pfizer-BioNTech No
22022-07-15Pfizer-BioNTech No
32022-09-16Pfizer-BioNTech No

Call center

4 call center cases

4 successful

See the call center timeline

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-08

Symptoms: Wet cough with runny nose, for about a week, but it was relatively mild.

Release 12 (Under 3) — day 14, dose 2, under 3

2022-07-29

Symptoms: He had a random virus that caused a low grade fever for about 12 hours and tiny red dots on his chest and back for about 48 hours. He tested negative on a covid home test and symptoms resolved quickly.

Release 12 (Under 3) — day 28, dose 2, under 3

2022-08-12

Symptoms: Runny nose, moderate respiratory distress, cough.

Release 12 (Under 3) — day 14, dose 3, under 3

2022-09-30

Symptoms: Ear infection that resulted in a burst eardrum.

Release 12 (Under 3) — day 35, dose 3, under 3

2022-10-21

Symptoms: Itchy, watery eyes, ear infection, post nasal drip, cough

Release 12 (Under 3) — 3 months, dose 3, under 3

2022-12-16

Symptoms: Colds, RSV, and Hand Foot Mouth disease.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDEar infection · · ✓
SDErythema · · ✓
SDEye pruritus · · ✓
SDHand-foot-and-mouth disease · · ✓
SDLacrimation increased · · ✓
SDNasopharyngitis · · ✓
SDProductive cough · · ✓
SDPyrexia · · ✓
SDRespiratory distress · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test negative · · ✓
SDTympanic membrane perforation · · ✓
SDUpper-airway cough syndrome · · ✓
SDViral infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release